DSCO
DSCO Articles
Discovery Laboratories Inc. (NASDAQ: DSCO) shares are up after a report that their drug Surfaxin, a respiratory distress syndrome treatment for premature infants, should gain FDA approval by May. In...
Published:
Alliance Data Systems (ADS) Deal for buy-out may be falling apart. Shares fall to $39.54 from 52-week high of $80.79. Image Entertainment (DISK) Dispute with creditors. Drops to $1.04 from 52-week...
Published:
(A) Agilent reiterated guidance after completing Stratagene buyout.(ADCT) ADC Telecom trading up 3% after posting $0.35 EPS vs $0.24 estimates.(ANN) Ann Taylor May s-s-s -4.6% versus -3.1%...
Published: